{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:37:00Z","timestamp":1776731820880,"version":"3.51.2"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Huai\u2019an Natural Science Research Program","award":["HABL202233"],"award-info":[{"award-number":["HABL202233"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15746-4","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:54:29Z","timestamp":1773046469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amino acid metabolism-related genes signature correlates with immune infiltration and predicts clinic prognosis in osteosarcoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Deshuang","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"15746_CR1","doi-asserted-by":"publisher","first-page":"151654","DOI":"10.1016\/j.anndiagpath.2020.151654","volume":"49","author":"F Jafari","year":"2020","unstructured":"Jafari F, Javdansirat S, Sanaie S, Naseri A, Shamekh A, Rostamzadeh D, et al. Osteosarcoma: A comprehensive review of management and treatment strategies. Annals Diagn Pathol. 2020;49:151654. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151654.","journal-title":"Annals Diagn Pathol"},{"key":"15746_CR2","doi-asserted-by":"publisher","unstructured":"Song Y, Xu Y, Zhu X, Fu J, Deng C, Chen H, et al. Immune landscape of the tumor microenvironment identifies prognostic gene signature CD4\/CD68\/CSF1R in osteosarcoma. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.01198.","DOI":"10.3389\/fonc.2020.01198"},{"issue":"19991015","key":"15746_CR3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/(sici)1097-0142","volume":"86","author":"SC Kaste","year":"1999","unstructured":"Kaste SC, Pratt CB, Cain AM, Jones-Wallace DJ, Rao BN. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer. 1999;86(19991015):1602\u20138. https:\/\/doi.org\/10.1002\/(sici)1097-0142. )86:8%253C1602::aid-cncr31%253E3.0.co;2-r.","journal-title":"Cancer"},{"key":"15746_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1053\/j.sempedsurg.2005.11.005","volume":"15","author":"MT Harting","year":"2006","unstructured":"Harting MT, Blakely ML. Management of osteosarcoma pulmonary metastases. Semin Pediatr Surg. 2006;15:25\u20139. https:\/\/doi.org\/10.1053\/j.sempedsurg.2005.11.005.","journal-title":"Semin Pediatr Surg"},{"key":"15746_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jso.21140","volume":"98","author":"G Bacci","year":"2008","unstructured":"Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98:415\u201320. https:\/\/doi.org\/10.1002\/jso.21140.","journal-title":"J Surg Oncol"},{"key":"15746_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s0959-8049(01)00004-1","volume":"37","author":"CA Stiller","year":"2001","unstructured":"Stiller CA, Craft AW, Corazziari I, EUROCARE Working Group. Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. Eur J Cancer. 2001;37:760\u20136. https:\/\/doi.org\/10.1016\/s0959-8049(01)00004-1.","journal-title":"Eur J Cancer"},{"key":"15746_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/bjc.2014.585","volume":"112","author":"NC Daw","year":"2015","unstructured":"Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, et al. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer. 2015;112:278\u201382. https:\/\/doi.org\/10.1038\/bjc.2014.585.","journal-title":"Br J Cancer"},{"key":"15746_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/os.13243","volume":"14","author":"G Xu","year":"2022","unstructured":"Xu G, Wu H, Zhang Y, Xu Y, Guo X, Baklaushev VP, et al. Risk and prognostic factors for different organ metastasis in primary osteosarcoma: A large Population-Based analysis. Orthop Surg. 2022;14:714\u20139. https:\/\/doi.org\/10.1111\/os.13243.","journal-title":"Orthop Surg"},{"key":"15746_CR9","doi-asserted-by":"publisher","first-page":"E976","DOI":"10.3390\/cells9040976","volume":"9","author":"I Corre","year":"2020","unstructured":"Corre I, Verrecchia F, Crenn V, Redini F, Trichet V. The osteosarcoma microenvironment: A complex but targetable ecosystem. Cells. 2020;9:E976. https:\/\/doi.org\/10.3390\/cells9040976.","journal-title":"Cells"},{"key":"15746_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122:150\u20136. https:\/\/doi.org\/10.1038\/s41416-019-0620-5.","journal-title":"Br J Cancer"},{"key":"15746_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/cancers11050675","volume":"11","author":"B-H Choi","year":"2019","unstructured":"Choi B-H, Coloff JL. The diverse functions of Non-Essential amino acids in cancer. Cancers (Basel). 2019;11:675. https:\/\/doi.org\/10.3390\/cancers11050675.","journal-title":"Cancers (Basel)"},{"key":"15746_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez J, Baudrier L, La K, Zhu XG, Fidelin J, Sviderskiy VO, et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumors. Nat Cell Biol. 2018;20:775\u201381. https:\/\/doi.org\/10.1038\/s41556-018-0118-z.","journal-title":"Nat Cell Biol"},{"key":"15746_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41556-018-0125-0","volume":"20","author":"LB Sullivan","year":"2018","unstructured":"Sullivan LB, Luengo A, Danai LV, Bush LN, Diehl FF, Hosios AM, et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat Cell Biol. 2018;20:782\u20138. https:\/\/doi.org\/10.1038\/s41556-018-0125-0.","journal-title":"Nat Cell Biol"},{"key":"15746_CR14","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/ijc.29535","volume":"137","author":"M Hassanein","year":"2015","unstructured":"Hassanein M, Qian J, Hoeksema MD, Wang J, Jacobovitz M, Ji X, et al. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int J Cancer. 2015;137:1587\u201397. https:\/\/doi.org\/10.1002\/ijc.29535.","journal-title":"Int J Cancer"},{"key":"15746_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41420-022-01029-x","volume":"8","author":"S Lin","year":"2022","unstructured":"Lin S, Miao Y, Zheng X, Dong Y, Yang Q, Yang Q, et al. ANGPTL4 negatively regulates the progression of osteosarcoma by remodeling branched-chain amino acid metabolism. Cell Death Discov. 2022;8:225. https:\/\/doi.org\/10.1038\/s41420-022-01029-x.","journal-title":"Cell Death Discov"},{"key":"15746_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly B, Pearce EL. Amino assets: how amino acids support immunity. Cell Metabol. 2020;32:154\u201375. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.010.","journal-title":"Cell Metabol"},{"key":"15746_CR17","doi-asserted-by":"publisher","first-page":"e957994","DOI":"10.4161\/21624011.2014.957994","volume":"3","author":"E Vacchelli","year":"2014","unstructured":"Vacchelli E, Aranda F, Eggermont A, Saut\u00e8s-Fridman C, Tartour E, Kennedy EP, et al. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2014;3:e957994. https:\/\/doi.org\/10.4161\/21624011.2014.957994.","journal-title":"Oncoimmunology"},{"key":"15746_CR18","doi-asserted-by":"publisher","first-page":"e2655","DOI":"10.1038\/cddis.2016.222","volume":"8","author":"W Ren","year":"2017","unstructured":"Ren W, Liu G, Yin J, Tan B, Wu G, Bazer FW, et al. Amino-acid transporters in T-cell activation and differentiation. Cell Death Dis. 2017;8:e2655. https:\/\/doi.org\/10.1038\/cddis.2016.222.","journal-title":"Cell Death Dis"},{"key":"15746_CR19","doi-asserted-by":"publisher","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","DOI":"10.1073\/pnas.0506580102"},{"key":"15746_CR20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"15746_CR21","doi-asserted-by":"publisher","unstructured":"Qian H, Lei T, Hu Y, Lei P. Expression of Lipid-Metabolism genes is correlated with immune microenvironment and predicts prognosis in osteosarcoma. Front CELL Dev BIOLOGY. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.673827.","DOI":"10.3389\/fcell.2021.673827"},{"key":"15746_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47\u201347. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"15746_CR23","doi-asserted-by":"publisher","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"15746_CR24","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"key":"15746_CR25","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.\u00a0","DOI":"10.1186\/1471-2105-14-7"},{"key":"15746_CR26","doi-asserted-by":"publisher","first-page":"17647","DOI":"10.18632\/aging.103838","volume":"12","author":"F Wen","year":"2020","unstructured":"Wen F, Huang J, Lu X, Huang W, Wang Y, Bai Y, et al. Identification and prognostic value of metabolism-related genes in gastric cancer. Aging. 2020;12:17647\u201361. https:\/\/doi.org\/10.18632\/aging.103838.","journal-title":"Aging"},{"key":"15746_CR27","doi-asserted-by":"publisher","first-page":"644220","DOI":"10.3389\/fcell.2021.644220","volume":"9","author":"G Chao-yang","year":"2021","unstructured":"Chao-yang G, Rong T, Yong-qiang S, Tai-cong L, Kai-sheng Z, Wei N, et al. Prognostic signatures of metabolic genes and Metabolism-Related long Non-coding RNAs accurately predict overall survival for osteosarcoma patients. Front Cell Dev Biol. 2021;9:644220. https:\/\/doi.org\/10.3389\/fcell.2021.644220.","journal-title":"Front Cell Dev Biol"},{"key":"15746_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"40","author":"D Sun","year":"2022","unstructured":"Sun D, Guan X, Moran AE, Wu L-Y, Qian DZ, Schedin P, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2022;40:527\u201338. https:\/\/doi.org\/10.1038\/s41587-021-01091-3.","journal-title":"Nat Biotechnol"},{"key":"15746_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MGV Heiden","year":"2017","unstructured":"Heiden MGV, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657\u201369. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039.","journal-title":"Cell"},{"key":"15746_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2019.06.006","volume":"57","author":"C Thakur","year":"2019","unstructured":"Thakur C, Chen F. Connections between metabolism and epigenetics in cancers. Sem Cancer Biol. 2019;57:52\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.006.","journal-title":"Sem Cancer Biol"},{"key":"15746_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-020-01269-4","volume":"19","author":"S Shen","year":"2020","unstructured":"Shen S, Yao T, Xu Y, Zhang D, Fan S, Ma J. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19:151. https:\/\/doi.org\/10.1186\/s12943-020-01269-4.","journal-title":"Mol Cancer"},{"key":"15746_CR32","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/cancers12061371","volume":"12","author":"R Fritsche-Guenther","year":"2020","unstructured":"Fritsche-Guenther R, Gloaguen Y, Kirchner M, Mertins P, Tunn P-U, Kirwan JA. Progression-Dependent altered metabolism in osteosarcoma resulting in different nutrient source dependencies. Cancers (Basel). 2020;12:1371. https:\/\/doi.org\/10.3390\/cancers12061371.","journal-title":"Cancers (Basel)"},{"key":"15746_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-022-01228-4","author":"K Tian","year":"2022","unstructured":"Tian K, Qi W, Yan Q, Lv M, Song D. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients. Invest New Drugs. 2022. https:\/\/doi.org\/10.1007\/s10637-022-01228-4.","journal-title":"Invest New Drugs"},{"key":"15746_CR34","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.26355\/eurrev_202204_28624","volume":"26","author":"W-B Zhang","year":"2022","unstructured":"Zhang W-B, Han F-M, Liu L-M, Jin H-B, Yuan X-Y, Shang H-S. Characterizing the critical role of metabolism in osteosarcoma based on Establishing novel molecular subtypes. Eur Rev Med Pharmacol Sci. 2022;26:2926\u201343. https:\/\/doi.org\/10.26355\/eurrev_202204_28624.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"15746_CR35","doi-asserted-by":"publisher","unstructured":"Wan B, Wang R, Nie J, Sun Y, Zhang B, Liu W et al. Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity. J Oncology. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/6649412.","DOI":"10.1155\/2021\/6649412"},{"key":"15746_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41416-020-01179-8","volume":"124","author":"I Khan","year":"2021","unstructured":"Khan I, Steeg PS. Endocytosis: a pivotal pathway for regulating metastasis. Br J Cancer. 2021;124:66\u201375. https:\/\/doi.org\/10.1038\/s41416-020-01179-8.","journal-title":"Br J Cancer"},{"key":"15746_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","volume":"12","author":"L Yang","year":"2019","unstructured":"Yang L, Li A, Lei Q, Zhang Y. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J Hematol Oncol. 2019;12:125. https:\/\/doi.org\/10.1186\/s13045-019-0804-8.","journal-title":"J Hematol Oncol"},{"key":"15746_CR38","doi-asserted-by":"publisher","first-page":"156094","DOI":"10.1016\/j.phymed.2024.156094","volume":"135","author":"P Zheng","year":"2024","unstructured":"Zheng P, Xu D, Cai Y, Zhu L, Xiao Q, Peng W, et al. A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1. Phytomedicine. 2024;135:156094. https:\/\/doi.org\/10.1016\/j.phymed.2024.156094.","journal-title":"Phytomedicine"},{"key":"15746_CR39","doi-asserted-by":"publisher","first-page":"e002840","DOI":"10.1136\/jitc-2021-002840","volume":"9","author":"R Qin","year":"2021","unstructured":"Qin R, Zhao C, Wang C-J, Xu W, Zhao J-Y, Lin Y, et al. Tryptophan potentiates CD8\u2009+\u2009T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation. J Immunother Cancer. 2021;9:e002840. https:\/\/doi.org\/10.1136\/jitc-2021-002840.","journal-title":"J Immunother Cancer"},{"key":"15746_CR40","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/ijc.28547","volume":"134","author":"B Uranbileg","year":"2014","unstructured":"Uranbileg B, Enooku K, Soroida Y, Ohkawa R, Kudo Y, Nakagawa H, et al. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential: mitochondrial creatine kinase and hepatocellular carcinoma. Int J Cancer. 2014;134:2189\u201398. https:\/\/doi.org\/10.1002\/ijc.28547.","journal-title":"Int J Cancer"},{"key":"15746_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2012.08.147","volume":"427","author":"X-L Qian","year":"2012","unstructured":"Qian X-L, Li Y-Q, Gu F, Liu F-F, Li W-D, Zhang X-M, et al. Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients. Biochem Biophys Res Commun. 2012;427:60\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2012.08.147.","journal-title":"Biochem Biophys Res Commun"},{"key":"15746_CR42","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1038\/s41598-017-05819-7","volume":"7","author":"H Wang","year":"2017","unstructured":"Wang H, Tang M, Ou L, Hou M, Feng T, Huang Y-E, et al. Biological analysis of cancer specific MicroRNAs on function modeling in osteosarcoma. Sci Rep. 2017;7:5382. https:\/\/doi.org\/10.1038\/s41598-017-05819-7.","journal-title":"Sci Rep"},{"key":"15746_CR43","doi-asserted-by":"publisher","first-page":"17970","DOI":"10.18632\/aging.203345","volume":"13","author":"T-J Kao","year":"2021","unstructured":"Kao T-J, Wu C-C, Phan NN, Liu Y-H, Ta HDK, Anuraga G, et al. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer. Aging. 2021;13:17970. https:\/\/doi.org\/10.18632\/aging.203345.","journal-title":"Aging"},{"key":"15746_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00795-017-0177-4","volume":"51","author":"K Nakamura","year":"2018","unstructured":"Nakamura K, Akiba J, Ogasawara S, Naito Y, Nakayama M, Abe Y, et al. SUOX is negatively associated with multistep carcinogenesis and proliferation in oral squamous cell carcinoma. Med Mol Morphol. 2018;51:102\u201310. https:\/\/doi.org\/10.1007\/s00795-017-0177-4.","journal-title":"Med Mol Morphol"},{"key":"15746_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00795-018-00214-1","volume":"52","author":"H Kurose","year":"2019","unstructured":"Kurose H, Naito Y, Akiba J, Kondo R, Ogasawara S, Kusano H, et al. High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer. Med Mol Morphol. 2019;52:164\u201372. https:\/\/doi.org\/10.1007\/s00795-018-00214-1.","journal-title":"Med Mol Morphol"},{"key":"15746_CR46","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.21873\/anticanres.15913","volume":"42","author":"Y Naito","year":"2022","unstructured":"Naito Y, Akiba J, Kinjo Y, Sadashima E, Ogata T, Yano Y, et al. Predictive and prognostic value of SUOX expression in pancreatic ductal adenocarcinoma. Anticancer Res. 2022;42:4145\u201351. https:\/\/doi.org\/10.21873\/anticanres.15913.","journal-title":"Anticancer Res"},{"key":"15746_CR47","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jhep.2013.04.028","volume":"59","author":"G-Z Jin","year":"2013","unstructured":"Jin G-Z, Yu W-L, Dong H, Zhou W-P, Gu Y-J, Yu H, et al. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma. J Hepatol. 2013;59:510\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.028.","journal-title":"J Hepatol"},{"key":"15746_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-019-0106-z","volume":"19","author":"H Lemos","year":"2019","unstructured":"Lemos H, Huang L, Prendergast GC, Mellor AL. Immune control by amino acid catabolism during tumorigenesis and therapy. Nat Rev Cancer. 2019;19:162\u201375. https:\/\/doi.org\/10.1038\/s41568-019-0106-z.","journal-title":"Nat Rev Cancer"},{"key":"15746_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73:377\u201392. https:\/\/doi.org\/10.1007\/s00018-015-2070-4.","journal-title":"Cell Mol Life Sci"},{"key":"15746_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2217\/imt-2016-0118","volume":"9","author":"E Timosenko","year":"2017","unstructured":"Timosenko E, Hadjinicolaou AV, Cerundolo V. Modulation of cancer-specific immune responses by amino acid degrading enzymes. Immunotherapy. 2017;9:83\u201397. https:\/\/doi.org\/10.2217\/imt-2016-0118.","journal-title":"Immunotherapy"},{"key":"15746_CR51","doi-asserted-by":"publisher","first-page":"e990800","DOI":"10.4161\/2162402X.2014.990800","volume":"4","author":"B Fritzsching","year":"2015","unstructured":"Fritzsching B, Fellenberg J, Moskovszky L, S\u00e1pi Z, Krenacs T, Machado I, et al. CD8+\/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study. Oncoimmunology. 2015;4:e990800. https:\/\/doi.org\/10.4161\/2162402X.2014.990800.","journal-title":"Oncoimmunology"},{"key":"15746_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst J, Ahrends T, B\u0105ba\u0142a N, Melief CJM, Kastenm\u00fcller W. CD4\u2009+\u2009T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18:635\u201347. https:\/\/doi.org\/10.1038\/s41577-018-0044-0.","journal-title":"Nat Rev Immunol"},{"key":"15746_CR53","doi-asserted-by":"publisher","first-page":"672361","DOI":"10.3389\/fvets.2021.672361","volume":"8","author":"WC Kisseberth","year":"2021","unstructured":"Kisseberth WC, Lee DA. Adoptive natural killer cell immunotherapy for canine osteosarcoma. Front Vet Sci. 2021;8:672361. https:\/\/doi.org\/10.3389\/fvets.2021.672361.","journal-title":"Front Vet Sci"},{"key":"15746_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-030-43032-0_12","volume":"1257","author":"BP Tullius","year":"2020","unstructured":"Tullius BP, Setty BA, Lee DA. Natural killer cell immunotherapy for osteosarcoma. Adv Exp Med Biol. 2020;1257:141\u201354. https:\/\/doi.org\/10.1007\/978-3-030-43032-0_12.","journal-title":"Adv Exp Med Biol"},{"key":"15746_CR55","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/cells10071668","volume":"10","author":"C Cascini","year":"2021","unstructured":"Cascini C, Chiodoni C. The immune landscape of osteosarcoma: implications for prognosis and treatment response. Cells. 2021;10:1668. https:\/\/doi.org\/10.3390\/cells10071668.","journal-title":"Cells"},{"key":"15746_CR56","doi-asserted-by":"publisher","first-page":"586580","DOI":"10.3389\/fonc.2020.586580","volume":"10","author":"Z-W Luo","year":"2020","unstructured":"Luo Z-W, Liu P-P, Wang Z-X, Chen C-Y, Xie H. Macrophages in osteosarcoma immune microenvironment: implications for immunotherapy. Front Oncol. 2020;10:586580. https:\/\/doi.org\/10.3389\/fonc.2020.586580.","journal-title":"Front Oncol"},{"key":"15746_CR57","doi-asserted-by":"publisher","unstructured":"Li Q, Xiang M. Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin. 2021;1\u201312. https:\/\/doi.org\/10.1038\/s41401-021-00776-4.","DOI":"10.1038\/s41401-021-00776-4"},{"key":"15746_CR58","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang J, Zhu J, Lu S, Qin H, Zhou W. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated Immunomodulation and advanced by Exosomal engineering. J Controlled Release. 2025;382:113664. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113664.","journal-title":"J Controlled Release"},{"key":"15746_CR59","doi-asserted-by":"publisher","first-page":"730289","DOI":"10.3389\/fimmu.2021.730289","volume":"12","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang H, Sun Q, Geng R, Yuan F, Liu B, et al. Immunomodulatory effects of Tryptophan metabolism in the glioma tumor microenvironment. Front Immunol. 2021;12:730289. https:\/\/doi.org\/10.3389\/fimmu.2021.730289.","journal-title":"Front Immunol"},{"key":"15746_CR60","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, Liu Z, Yuan C, Luo Y, Chen Y, Zhang J, et al. Identification of cuproptosis-related LncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108198.","journal-title":"Comput Biol Med"},{"key":"15746_CR61","doi-asserted-by":"publisher","first-page":"1635449","DOI":"10.3389\/fphar.2025.1635449","volume":"16","author":"PS Ramalingam","year":"2025","unstructured":"Ramalingam PS, Chellasamy G, Hussain MS, Kodiveri Muthukaliannan G, Hussain T, Alrokayan S, et al. Synergistic anticancer effects of camptothecin and Sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma. Front Pharmacol. 2025;16:1635449. https:\/\/doi.org\/10.3389\/fphar.2025.1635449.","journal-title":"Front Pharmacol"},{"key":"15746_CR62","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"W-W Duan","year":"2024","unstructured":"Duan W-W, Yang L-T, Liu J, Dai Z-Y, Wang Z-Y, Zhang H, et al. A TGF-\u03b2 signaling-related LncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther. 2024;30:e14489. https:\/\/doi.org\/10.1111\/cns.14489.","journal-title":"CNS Neurosci Ther"},{"key":"15746_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223\u201349. https:\/\/doi.org\/10.1146\/annurev-pathol-042020-042741.","journal-title":"Annu Rev Pathol"},{"key":"15746_CR64","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nm.3161","volume":"19","author":"PF Robbins","year":"2013","unstructured":"Robbins PF, Lu Y-C, El-Gamil M, Li YF, Gross C, Gartner J, et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med. 2013;19:747\u201352. https:\/\/doi.org\/10.1038\/nm.3161.","journal-title":"Nat Med"},{"key":"15746_CR65","doi-asserted-by":"publisher","unstructured":"Korman AJ, Garrett-Thomson SC, Lonberg N. The foundations of immune checkpoint Blockade and the ipilimumab approval decennial. Nat Rev Drug Discov. 2021;1\u201320. https:\/\/doi.org\/10.1038\/s41573-021-00345-8.","DOI":"10.1038\/s41573-021-00345-8"},{"key":"15746_CR66","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s00432-020-03242-6","volume":"146","author":"Y Toda","year":"2020","unstructured":"Toda Y, Kohashi K, Yamada Y, Yoshimoto M, Ishihara S, Ito Y, et al. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions. J Cancer Res Clin Oncol. 2020;146:2607\u201320. https:\/\/doi.org\/10.1007\/s00432-020-03242-6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"15746_CR67","doi-asserted-by":"publisher","first-page":"e70689","DOI":"10.1371\/journal.pone.0070689","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Zhang Q, Chen W, Shan B, Ding Y, Zhang G, et al. B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. PLoS ONE. 2013;8:e70689. https:\/\/doi.org\/10.1371\/journal.pone.0070689.","journal-title":"PLoS ONE"},{"key":"15746_CR68","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.24976\/Discov.Med.202436187.151","volume":"36","author":"Z-F Zhao","year":"2024","unstructured":"Zhao Z-F, Cheng X-F, Yu M, Shi W-F, Zhang T. Baicalin plays an anti-osteosarcoma role in vitro and promotes osteogenic differentiation by inhibiting NF-\u03baB signaling. Discov Med. 2024;36:1648\u201356. https:\/\/doi.org\/10.24976\/Discov.Med.202436187.151.","journal-title":"Discov Med"},{"key":"15746_CR69","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","volume":"15","author":"N Dirckx","year":"2019","unstructured":"Dirckx N, Moorer MC, Clemens TL, Riddle RC. The role of osteoblasts in energy homeostasis. Nat Rev Endocrinol. 2019;15:651\u201365. https:\/\/doi.org\/10.1038\/s41574-019-0246-y.","journal-title":"Nat Rev Endocrinol"},{"key":"15746_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40425-015-0067-z","volume":"3","author":"DM Lussier","year":"2015","unstructured":"Lussier DM, Johnson JL, Hingorani P, Blattman JN. Combination immunotherapy with \u03b1-CTLA-4 and \u03b1-PD-L1 antibody Blockade prevents immune escape and leads to complete control of metastatic osteosarcoma. J Immunother Cancer. 2015;3:21. https:\/\/doi.org\/10.1186\/s40425-015-0067-z.","journal-title":"J Immunother Cancer"},{"key":"15746_CR71","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jvh.13886","volume":"30","author":"Q Ning","year":"2023","unstructured":"Ning Q, Yang T, Guo X, Huang Y, Gao Y, Liu M, et al. CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. J Viral Hepat. 2023;30:951\u20138. https:\/\/doi.org\/10.1111\/jvh.13886.","journal-title":"J Viral Hepat"},{"key":"15746_CR72","doi-asserted-by":"publisher","first-page":"1602252","DOI":"10.3389\/fimmu.2025.1602252","volume":"16","author":"PS Ramalingam","year":"2025","unstructured":"Ramalingam PS, Zhang L, Hussain MS, Khan G, Mawkili W, Hanbashi A, et al. Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma. Front Immunol. 2025;16:1602252. https:\/\/doi.org\/10.3389\/fimmu.2025.1602252.","journal-title":"Front Immunol"},{"key":"15746_CR73","doi-asserted-by":"publisher","unstructured":"Li L, Sun Y, Luo J, Liu M. Circulating immune cells and risk of osteosarcoma: a Mendelian randomization analysis. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1381212.","DOI":"10.3389\/fimmu.2024.1381212"},{"key":"15746_CR74","doi-asserted-by":"publisher","unstructured":"Huang L, Tan J, Lin P, Chen Z, Huang Q, Yao H, et al. Autoimmune encephalitis followed by hemophagocytic lymph histiocytosis: a case report. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1383255.","DOI":"10.3389\/fimmu.2024.1383255"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15746-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:40:15Z","timestamp":1776728415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15746-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15746"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15746-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"502"}}